Mustang Bio Inc (MBIO)
NASDAQ:MBIO
Total Valuation
Mustang Bio has a market cap or net worth of $5.87M. The enterprise value is -$11.39M.
Market Cap$5.87M
Enterprise Value-$11.39M
Share Statistics
Mustang Bio has 6,732,092 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,732,092
Owned by Insiders8.35%
Owned by Institutions1.35%
Financial Efficiency
Mustang Bio’s return on equity (ROE) is -0.20 and return on invested capital (ROIC) is -25.13%.
Return on Equity (ROE)-0.20
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-25.13%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee0.00
Profits Per Employee-320.17K
Employee Count6
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Mustang Bio is ―. Mustang Bio’s PEG ratio is 0.30.
PE Ratio―
PS Ratio0.00
PB Ratio5.05
Price to Fair Value5.05
Price to FCF-9.15
Price to Operating Cash Flow-1.07
PEG Ratio0.30
Income Statement
In the last 12 months, Mustang Bio had revenue of 0.00 and earned -1.92M in profits. Earnings per share was -0.39.
Revenue0.00
Gross Profit-41.00K
Operating Income-2.43M
Pretax Income-1.92M
Net Income-1.92M
EBITDA-2.39M
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was -5.26M and capital expenditures 0.00, giving a free cash flow of -5.26M billion.
Operating Cash Flow-5.26M
Free Cash Flow-5.26M
Free Cash Flow per Share-0.78
Dividends & Yields
Mustang Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change-42.59%
50-Day Moving Average0.90
200-Day Moving Average1.33
Relative Strength Index (RSI)39.31
Average Volume (3m)94.14K
Important Dates
Mustang Bio upcoming earnings date is May 9, 2025, TBA (Confirmed).
Last Earnings DateMar 24, 2025
Next Earnings DateMay 9, 2025
Ex-Dividend Date―
Financial Position
Mustang Bio as a current ratio of 2.22, with Debt / Equity ratio of 0.00%
Current Ratio2.22
Quick Ratio2.22
Debt to Market Cap0.00
Net Debt to EBITDA7.22
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Mustang Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Mustang Bio EV to EBITDA ratio is -12.92, with an EV/FCF ratio of -5.87.
EV to Sales0.00
EV to EBITDA-12.92
EV to Free Cash Flow-5.87
EV to Operating Cash Flow-5.87
Balance Sheet
Mustang Bio has $17.27M in cash and marketable securities with $0.00 in debt, giving a net cash position of $17.27M billion.
Cash & Marketable Securities$17.27M
Total Debt$0.00
Net Cash$17.27M
Net Cash Per Share$2.56
Tangible Book Value Per Share$0.19
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Mustang Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast98.58%